Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/32654
Title: | Gender-Affirming Hormone Therapy for the Trans, Gender Diverse, and Nonbinary Community: Coordinating World Professional Association for Transgender Health and Informed Consent Models of Care. | Austin Authors: | Solanki, Pravik;Colon-Cabrera, David;Barton, Chris;Locke, Peter;Cheung, Ada S ;Spanos, Cassandra;Grace, Julian;Erasmus, Jaco;Lane, Riki | Affiliation: | Department of General Practice, School of Public Health and Preventive Medicine, Monash University, Clayton, Australia. Department of Anthropology, School of Social Sciences, Monash University, Clayton, Australia.;Monash Health Gender Clinic, Hampton East, Australia. Department of General Practice, School of Public Health and Preventive Medicine, Monash University, Clayton, Australia. Equinox Clinic, Thorne Harbour Health, Fitzroy, Australia. Medicine (University of Melbourne) Monash Health Gender Clinic, Hampton East, Australia. |
Issue Date: | Mar-2023 | Date: | 2023-02 | Publication information: | Transgender Health 2023-04; 8(2) | Abstract: | Before commencing gender-affirming hormone therapy, people undergo assessments through the World Professional Association for Transgender Health (WPATH) model (typically with a mental health clinician), or an informed consent (IC) model (without a formal mental health assessment). Despite growing demand, these remain poorly coordinated in Australia. We aimed to compare clients attending WPATH and IC services; compare binary and nonbinary clients; and characterize clients with psychiatric diagnoses or longer assessments. Cross-sectional audit of clients approved for gender-affirming treatment (March 2017-2019) at a specialist clinic (WPATH model, n=212) or a primary care clinic (IC model, n=265). Sociodemographic, mental health, and clinical data were collected from electronic records, and analyzed with pairwise comparisons and multivariable regression. WPATH model clients had more psychiatric diagnoses (mean 1.4 vs. 1.1, p<0.001) and longer assessments for hormones (median 5 vs. 2 sessions, p<0.001) than IC model clients. More IC model clients than WPATH model clients were nonbinary (27% vs. 15%, p=0.016). Nonbinary clients had more psychiatric diagnoses (mean 1.7 vs. 1.1, p<0.001) and longer IC assessments (median 3 vs. 2 sessions, p<0.001) than binary clients. Total psychiatric diagnoses were associated with nonbinary identities (β 0.7, p=0.001) and health care cards (β 0.4, p=0.017); depression diagnoses were associated with regional/remote residence (adjusted odds ratio [aOR] 2.2, p=0.011); and anxiety disorders were associated with nonbinary identities (aOR 2.8, p=0.012) and inversely associated with employment (aOR 0.5, p=0.016). WPATH model clients are more likely to have binary identities, mental health diagnoses, and longer assessments than IC model clients. Better coordination is needed to ensure timely gender-affirming care. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/32654 | DOI: | 10.1089/trgh.2021.0069 | ORCID: | 0000-0002-5868-3962 0000-0001-5257-5525 |
Journal: | Transgender Health | Start page: | 137 | End page: | 148 | PubMed URL: | 37013095 | Type: | Journal Article | Subjects: | WPATH model gender-affirming hormone therapy informed consent model nonbinary transgender |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.